Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ida Mogensen (Enskededalen, Sweden), Ida Mogensen, Kjell Alving, Sven-Erik Dahlen, Bertil Forsberg, Christer Jansson, Andrei Malinovschi. Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation. Eur Respir J 2015; 46: Suppl. 59, 2085

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma Source: Annual Congress 2013 –Asthma Year: 2013 Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma Year: 2015 Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 iNOS expression is increased in peripheral airways of asthmatic patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Exhaled nitric oxide in diagnosis and management of respiratory diseases Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Prevalence and relationship of hypomagnesiemia with children bronchial asthma control Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015